[1]田瑞华,郑良楷,孔令员,等.TET2蛋白在不同分子亚型乳腺癌中的表达及意义[J].福建医药杂志,2017,39(3):89-91.
 TIAN Ruihua,ZHENG Liangkai,Kong Lingyuan,et al.Expression and significance of TET2 in different molecular subtypes of breast cancer[J].FUJIAN MEDICAL JOURNAL,2017,39(3):89-91.
点击复制

TET2蛋白在不同分子亚型乳腺癌中的表达及意义
分享到:

《福建医药杂志》[ISSN:1002-2600/CN:35-1071/R]

卷:
39
期数:
2017年3期
页码:
89-91
栏目:
实验诊断与临床
出版日期:
2017-06-15

文章信息/Info

Title:
Expression and significance of TET2 in different molecular subtypes of breast cancer
作者:
田瑞华郑良楷孔令员杨毅斌黄宗涌周巧蓉王莉萍张爱格
福建省厦门市妇幼保健院病理科厦门361003
Author(s):
TIAN RuihuaZHENG LiangkaiKong LingyuanYANG YibinHUANG ZongyongZHOU QiaorongWANG LipingZHANG Aige
关键词:
乳腺癌TET2分子亚型临床分期预后指标
Keywords:
breast cancerTET2molecular subtypeclinical stagesprognostic biological marker
分类号:
R737.9
摘要:
目的探讨TET2蛋白(ten-eleventranslocation2)在不同分子亚型乳腺癌组织中的表达特点及与乳腺癌各临床因素之间的关系.方法免疫组化检测155例乳腺癌中TET2、ER、PR、Ki67和HER2蛋白的表达水平,FISH技术检测HER2基因扩增情况,结合患者相关资料进行分析.结果TET2蛋白在LuminalB(HER2+)型乳腺癌组织中的表达水平明显下调(P<0.001),在HER2阳性的乳腺癌组织中也发现TET2表达水平下调(P<0.001),并且TET2表达水平还受到肿瘤大小和淋巴结转移等因素影响(P<0.001).结论TET2蛋白在不同分子亚型乳腺癌组织中的表达差异有统计学意义,并且与乳腺癌多项临床特征有关,可能有助于判断乳腺癌的预后.
Abstract:
Objective To investigate the expression of TET2(ten-eleven translocation 2)in breast cancer tissues of different subtypes and the correlation between TET2 expression and clinic features of breast cancer.Methods The expression of TET2,ER,PR,Ki67 and HER2 was detected by streptavidin-peroxidase(SP),the expression of HER2 was detected by FISH in 155 cases of breast cancer,and the related data were combined with to analyze.Results The expression of TET2 was significantly decreased in Luminal B HER2 positive breast cancer tissues compared to that in others(P<0.001).TET2 expression was also significantly decreased in breast cancer with higher expression of HER2(P<0.001),and was affected by tumor size,and lymph node metastasis (P<0.001).Conclusion The expression of TET2 shows significant difference among different molecular subtypes of breast cancer.It is also related to the clinical features of breast cancer,which indicates that TET2 may be a prognostic biological marker in breast cancer.

相似文献/References:

[1]韩蕾 林志武 陈晓耕.早期乳腺癌前哨淋巴结活检术125例临床分析[J].福建医药杂志,2017,39(5):52.
[2]王瑞娟 肖雪明 曾焕红 林 强.乳腺癌患者外周血循环肿瘤细胞检测的临床价值[J].福建医药杂志,2020,42(05):42.
[3]王一名,刘苏燕,谭娇丽,等.基于网络药理学探讨复方斑蝥胶囊调控乳腺癌铁死亡的机制研究[J].福建医药杂志,2024,46(01):106.[doi:10.20148/j.fmj.2024.01.030]
 WANG Yiming,LIU Suyan,TAN Jiaoli,et al.Research on the mechanism of compound mylabris capsules regulating ferroptosis in breast cancer based on network pharmacology and molecular docking[J].FUJIAN MEDICAL JOURNAL,2024,46(3):106.[doi:10.20148/j.fmj.2024.01.030]

备注/Memo

备注/Memo:
福建省卫生厅青年科研课题
更新日期/Last Update: 1900-01-01